[Hong Kong: Build an international authoritative regulatory agency for pharmaceuticals and devices and establish independent drug and device review and approval capabilities] September 16th, the "First Five-Year Plan for Economic and Social Development of the Hong Kong Special Administrative Region (2026-2030)" was announced today (September 16), which proposed to comprehensively deepen the regulatory reform of drugs and medical devices (drugs and devices), improve the regulatory system, align with international standards, establish independent drug and device review and approval capabilities, actively participate in the international drug and device regulatory arena, and strive for international authoritative certification. Promote the research and development of innovative drugs and medical devices, accelerate the launch and use of innovative drugs, and build Hong Kong into an international medical innovation hub. Enhance the role of the driving force for the development of pharmaceuticals and devices in the Guangdong-Hong Kong-Macao Greater Bay Area and improve people's health.